Work

ACVR1B ( ALK4 , activin receptor type 1B) gene mutations in pancreatic carcinoma

Year: 2001
Type: article
Study design: Observational Study
Abstract: DPC4 is known to mediate signals initiated by type beta transforming growth factor (TGFbeta) as well as by other TGFbeta superfamily ligands such as activin and BMP (bone morphogenic proteins), but mutational surveys of such non-TGFbeta receptors have been negative to date. Here we describe the gene structure and novel somatic mutations of the activin type I receptor, ACVR1B, in pancreatic cancer. ACVR1B has not been described previously as a mutated tumor-suppressor gene.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W2019400355
FWCI: 6.605
Cites: 29
Cited by: 155
Related to: 10